Ranolazine (Ranexa (TM)) for chronic stable angina

Canadian Agency for Drugs and Technologies in Health
Record ID 32007000676
English, French
Details
Project Status: Completed
URL for project: http://cadth.ca
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Canada
  • Chronic Disease
  • Clinical Trials as Topic
  • Drug Approval
  • Drug Therapy, Combination
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration
  • Acetanilides
  • Adrenergic beta-Antagonists
  • Angina Pectoris
  • Calcium Channel Blockers
  • Delayed-Action Preparations
  • Enzyme Inhibitors
  • Nitrates
  • Piperazines
  • Vasodilator Agents
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.